Services

    Expanding the development of innovative biotechnology treatments for the global market

    Joint bookrunner and joint lead manager on the Initial Public Offering (“IPO”) of the best performing secondary listing on HKEx, Hutchmed (China) Limited (“Hutchmed”).

    Sector Services
    Sub-sector Technology & Healthcare
    Location Hong Kong

    Opportunity

    Founded in 2000, Hutchmed is a global biopharmaceutical company based in China. Hutchmed focusses on the discovery, development and commercialisation of targeted therapies and immunotherapies for the treatment of patients with cancer and immunological diseases.

    The company is dual-listed in London and New York, with a proven track record of bringing innovative oncology drugs from discovery to full commercialisation.

    In 2021, Hutchmed sought primary listing status on the Hong Kong Stock Exchange (HKEX) and additional investment to support further research and development.


    Approach

    Macquarie Capital made use of its extensive global network to successfully facilitate meetings between Hutchmed and high-quality institutional investors across Asia, Europe, and Australia.

    Macquarie secured investor interest from reputable Australian long-only funds and achieved significant demand in the bookbuild process.

    Outcome

    The IPO of Hutchmed has raised $US618 million and recorded the highest first trading day share price performance among all secondary listed companies on Hong Kong Stock Exchange to date.

    The funds raised will be used to advance Hutchmed’s late-stage clinical programs and fund the continued expansion and development of cancer and immunological treatments for patients.

    Highest first trading day share price

    performance among all secondary listed companies on HKEx to date.

    First secondary listing

    on HKEx with cornerstone investments.

    Hutchmed has taken the iconic ticker

    (13 HK) once belonged to Hutchison Whampoa Ltd, one of the largest companies previously listed on HKEx.

    Related insights

    Filter0 items

    Filter

    Technology and services

    View results

    No results message:
    Displayed when filters returns no results.

    Service unavailable:
    Displayed when filter service cannot be reached.

    Sorry, this service is currently unavailable.

    Please try again later.